Trial result ·
Press needle combined with plum blossom needle improves diabetic peripheral neuropathy by inhibiting pro-inflammatory cytokines: a randomized controlled trial.
Written based on 1 research study on PubMed, searched on 15 Nov 2026.
What was studied
This trial looked at people with nerve damage caused by diabetes. In total, 225 people took part, and chance decided their group. For 6 months, everyone took the drugs epalrestat and mecobalamin. One group also got press needles and plum blossom needle tapping. The sham group got fake needling with blunt needles that did nothing. The control group got no extra needle care.
What they found
After 6 months, the needle group had lower blood levels of inflammation markers. These markers were TNF-α, IL-6 and IL-1β. Levels were lower than in both other groups. In the needle group, all measured nerve signal speeds improved from the start. After care, the other groups did worse than the needle group on some nerve tests. Symptom scores in the needle group improved more than in the other groups.
What it means for patients
The authors say this needle care lowers signs of inflammation. They say it also speeds nerve signals and helps symptom scores. They report it helps both small and large nerve fibers. They say it was safe and well tolerated. They think it may work by calming lasting nerve inflammation.
Why it is not certain yet
The abstract gives no safety numbers or side effect details. It does not say how long the effects last after 6 months. The authors say the way it works only may involve inflammation. Results from one trial need checking in more trials.
Source
Press needle combined with plum blossom needle improves diabetic peripheral neuropathy by inhibiting pro-inflammatory cytokines: a randomized controlled trial.
PubMed · PMID 42755651We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Diabetic neuropathy publications